Keene soon finds herself the key figure in the planned merger of an American biotech company and an Indian genetics company. At stake, a ...
News
- Review: Stacey Abrams writes a legal-political thriller
- EXCLUSIVE: Lawmakers, citing Sinclair report, seek classified briefing on COVID-19 study
asks questions to Dr. Richard Bright, former director of the Biomedical Advanced Research and Development Authority, during a House Energy and ...
- Talis: Q1 Earnings Snapshot
(AP) _ Talis Biomedical Corp. (TLIS) on Tuesday reported a loss of $60.5 million in its first quarter. On a per-share basis, the Menlo Park, California- ...
- Vascular Biogenics: Q1 Earnings Snapshot
The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share. The gene therapy biotech company ...
- FibroGen: Q1 Earnings Snapshot
The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 90 cents per share. The biotech drug developer ...